Role of Calcium-dependent Protein Kinases in Chronic Myeloid Leukemia: Combined Effects of PKC and BCR-ABL Signaling on Cellular Alterations During Leukemia Development

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2014 Jul 22

PMID 25045273

Citations 8

Authors

Andre L Mencalha

Stephany Correa

Eliana Abdelhay

Affiliations

Soon will be listed here.

Abstract

Calcium-dependent protein kinases (PKCs) function in a myriad of cellular processes, including cell-cycle regulation, proliferation, hematopoietic stem cell differentiation, apoptosis, and malignant transformation. PKC inhibitors, when targeted to these pathways, have demonstrated efficacy against several types of solid tumors as well as leukemia. Chronic myeloid leukemia (CML) represents 20% of all adult leukemia. The aberrant Philadelphia chromosome has been reported as the main cause of CML development in hematopoietic stem cells, due to the formation of the BCR-ABL oncogene. PKCs and BCR-ABL coordinate several signaling pathways that are crucial to cellular malignant transformation. Experimental and clinical evidence suggests that pharmacological approaches using PKC inhibitors may be effective in the treatment of CML. This mini review summarizes articles from the National Center for Biotechnology Information website that have shown evidence of the involvement of PKC in CML.

Citing Articles

Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential.

Immanuel T, Li J, Green T, Bogdanova A, Kalev-Zylinska M Front Oncol. 2022; 12:1010506.

PMID: 36330491 PMC: 9623116. DOI: 10.3389/fonc.2022.1010506.

The Anti-Leukemic Activity of Natural Compounds.

Cotoraci C, Ciceu A, Sasu A, Miutescu E, Hermenean A Molecules. 2021; 26(9).

PMID: 34063044 PMC: 8124534. DOI: 10.3390/molecules26092709.

Homologous recombination defects and how they affect replication fork maintenance.

Son M, Hasty P AIMS Genet. 2019; 5(4):192-211.

PMID: 31435521 PMC: 6690234. DOI: 10.3934/genet.2018.4.192.

Deregulation of calcium homeostasis in Bcr-Abl-dependent chronic myeloid leukemia.

Cabanas H, Harnois T, Magaud C, Cousin L, Constantin B, Bourmeyster N Oncotarget. 2018; 9(41):26309-26327.

PMID: 29899861 PMC: 5995172. DOI: 10.18632/oncotarget.25241.

Synthesis and Cytotoxicity against K562 Cells of 3-O-Angeloyl-20-O-acetyl Ingenol, a Derivative of Ingenol Mebutate.

Liu M, Chen F, Yu R, Zhang W, Han M, Liu F Int J Mol Sci. 2016; 17(8).

PMID: 27548156 PMC: 5000744. DOI: 10.3390/ijms17081348.

References

Obrian C, Vogel V, Singletary S, Ward N . Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res. 1989; 49(12):3215-7. View

Michor F . Chronic myeloid leukemia blast crisis arises from progenitors. Stem Cells. 2007; 25(5):1114-8. DOI: 10.1634/stemcells.2006-0638. View

Melo J . The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood. 1996; 88(7):2375-84. View

Redig A, Platanias L . The protein kinase C (PKC) family of proteins in cytokine signaling in hematopoiesis. J Interferon Cytokine Res. 2007; 27(8):623-36. DOI: 10.1089/jir.2007.0007. View

Zheng C, Li L, Haak M, Brors B, Frank O, Giehl M . Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis. Leukemia. 2006; 20(6):1028-34. DOI: 10.1038/sj.leu.2404227. View

Li H, Weinstein I . Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells. Cancer Res. 2006; 66(23):11399-408. DOI: 10.1158/0008-5472.CAN-06-2386. View

Murray N, Velasco M, Gatalica Z, Fields A . Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis. Cancer Res. 2001; 61(4):1375-81. View

Parker P, Justilien V, Riou P, Linch M, Fields A . Atypical protein kinase Cι as a human oncogene and therapeutic target. Biochem Pharmacol. 2013; 88(1):1-11. PMC: 3944347. DOI: 10.1016/j.bcp.2013.10.023. View

Zhu S, Yao F, Li W, Wan J, Zhang Y, Tang Z . PKC?-dependent activation of the ubiquitin proteasome system is responsible for high glucose-induced human breast cancer MCF-7 cell proliferation, migration and invasion. Asian Pac J Cancer Prev. 2013; 14(10):5687-92. DOI: 10.7314/apjcp.2013.14.10.5687. View

10.

Kazi J, Kabir N, Ronnstrand L . Protein kinase C (PKC) as a drug target in chronic lymphocytic leukemia. Med Oncol. 2013; 30(4):757. DOI: 10.1007/s12032-013-0757-7. View

11.

Regala R, Weems C, Jamieson L, Copland J, Thompson E, Fields A . Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity. J Biol Chem. 2005; 280(35):31109-15. DOI: 10.1074/jbc.M505402200. View

12.

Woloschak G . Is PKC activation required for leukemia cell differentiation?. Leuk Res. 1997; 21(5):411-4. DOI: 10.1016/s0145-2126(96)00121-x. View

13.

Shiota M, Yokomizo A, Takeuchi A, Imada K, Kashiwagi E, Song Y . Inhibition of protein kinase C/Twist1 signaling augments anticancer effects of androgen deprivation and enzalutamide in prostate cancer. Clin Cancer Res. 2013; 20(4):951-61. DOI: 10.1158/1078-0432.CCR-13-1809. View

14.

Aziz M, Manoharan H, Sand J, Verma A . Protein kinase Cepsilon interacts with Stat3 and regulates its activation that is essential for the development of skin cancer. Mol Carcinog. 2007; 46(8):646-53. DOI: 10.1002/mc.20356. View

15.

Batliwalla F, Advani S, Gothoskar B, Zingde S . Differential phosphorylation in normal and leukemic granulocytes in response to phorbol 12-myristate 13-acetate. Leuk Res. 1994; 18(5):327-36. DOI: 10.1016/0145-2126(94)90016-7. View

16.

Kinehara M, Kawamura S, Tateyama D, Suga M, Matsumura H, Mimura S . Protein kinase C regulates human pluripotent stem cell self-renewal. PLoS One. 2013; 8(1):e54122. PMC: 3549959. DOI: 10.1371/journal.pone.0054122. View

17.

Higuchi S, Ii M, Zhu P, Ashraf M . Delta-opioid receptor activation promotes mesenchymal stem cell survival via PKC/STAT3 signaling pathway. Circ J. 2011; 76(1):204-12. DOI: 10.1253/circj.cj-11-0309. View

18.

Lindner I, Kharfan-Dabaja M, Ayala E, Kolonias D, Carlson L, Beazer-Barclay Y . Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL. J Immunol. 2003; 171(4):1780-91. DOI: 10.4049/jimmunol.171.4.1780. View

19.

Fowler D . Doubling down on PKC benefits allogeneic BMT. Blood. 2013; 122(14):2298-9. PMC: 3790501. DOI: 10.1182/blood-2013-08-519900. View

20.

Lim Y, Wong S, Lau G, Witte O, Colicelli J . BCR/ABL inhibition by an escort/phosphatase fusion protein. Proc Natl Acad Sci U S A. 2000; 97(22):12233-8. PMC: 17324. DOI: 10.1073/pnas.210253497. View